EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Knowledge Gain Through High Parallel Bioprocess Setups
Product Life Cycle Manager, Eppendorf AG
Sebastian Kleebank studied Bioengineering at the University of Applied Sciences in Juelich followed by his PhD at the RWTH Aachen Institute for Molecular Biotechnology In his actual position as a Product Life Cycle Manager at Eppendorf AG Business Unit Bioprocess he is responsible for the smallscale product portfolio During his years in the bioprocess industry he gained a lot of experience in sma...
Articles
Are We Ready to Ship Billions of COVID Vaccines Worldwide?
Theres no denying it has been a year of immense difficulty and disruptionMany now look forward to and the muchanticipated prospect of COVID vaccines as the gateway to global recovery Naturally as one of the the worlds leading logistics companies FedEx has an important role to play in vaccine shipment
Research Insights
A Proteomic Perspective and Involvement of Cytokines in SARS-CoV-2 Infection
Infection with the SARSCoV virus results in manifestation of several clinical observations from asymptomatic to multiorgan failure
Case Studies
Isolation Technology: Case Study
A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying process The following requirements had to be met To provide a safe barrier between the operator and the active drug substance to provide both operator and product protect
Techno Trends
Novel Cancer Immunotherapy Tiragolumab Discovered for the Treatment of Non-Small Cell Lung Cancer
Tiragolumab a novel cancer immunotherapy discovered for the treatment of metastatic Nonsmall Cell Lung Cancer NSCLC Tiragolumab is the first antiTIGIT molecule introduced to bind with TIGIT a protein receptor on immune cells It functions as an immune amplifier by improving the bodys immune response By combining with TIGIT
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Tobacco-style Label Warning on Alcohol Products
Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry
Covid -19 and Nanoparticles
Ramendra Pati Pandey is an Assistant Professor in the Department of Biotechnology/Microbiology/Biomedical Engineering at the SRM University, Delhi-NCR, Sonepat. He was a FAPESP Post-Doctoral Fellow a very prestigious fellowship of Latin America at the Department of Medicine-InCor/HC-FMUSP, University of Sao Paulo, Brazil.
Deepika has completed here master degree from Department of Biotechnology, Deenbandhu Choturam University and Technology, Sonepat, Haryana, India.
Reshma completed her master's degree from the Royal Global University in Guwahati, Assam, India's department of Biotechnology.
Neehasri holds a master's degree in Zoology from Gauhati University in Guwahati, Assam, India, and has also passed the B.Ed. professional exam.
Trump Tariff Tyranny and Pharma Preparedness
Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry and academic accomplishments. During his industry stay he became a seasoned scientist and dealt with challenging NCE/NDA development. He is on advisory boards of some international research-based companies of India, New Zealand and Europe. Academics and Research being close to his heart, he has published more than 110 manuscripts in the journals of international repute and has been granted 02 Indian patent and filed for 04. He has contributed several chapters in books published by reputed authors like Elsevier and Bentham. He is amongst the very few scientists globally who has an expertise in Humic substances research. A well-travelled scientist; he has delivered scientific addresses in countries like USA, Austria, Japan, Netherlands, Turkey, Estonia, Spain and Russia. He has been Elite Fellow at University of Malaya (Malaysia) for the last 5 years where he takes classes on the topics related to industrial pharmacy.
CAR-T Cell Therapy and NexCAR19
Dr Ashwini Kumar is presently working as an Assistant Professor in the Biotechnology and Bioinformatics Area at NIIT University, Neemrana (Rajasthan), India. Biomaterial science has been the main focus of Ashwini's research, particularly in the area of cutting-edge drug delivery techniques. His research's intended uses are developing minimally invasive and non-invasive medication delivery strategies to improve patient compliance and outcomes. Two other area that pique his curiosity are tissue engineering and diabetes. Ashwini is the author for twenty-two journal articles published in both domestic and foreign journals, eight book chapters, a book. In addition, he has a patent for his PhD work. He has been asked to participate in juries and speak on several national scientific venues. He has been working as a reviewer for reputable journals published by Frontiers, Elsevier, and Wiley. He is a guest editor of Frontiers in Medical Technology, a focused journal from Frontiers Publications, and a regular reviewer of Materials and Design, Elsevier. He is a life member of Asian Polymer Association.
Current Research on Plant miRNA and Its Application in Disease Prevention
Atiya Saiyed is a Ph D student at Iladevi Cataract and IOL Research Centre and registered at Manipal Academy of Higher Education, Manipal. She is Senior Research Fellow from Indian Council of Medical Research, New Delhi. Atiya does research in the fields of molecular biology, cell biology, and cancer biology.
Abhay R. Vasavada is a well-known ophthalmologist who founded Raghudeep Eye Clinic (REH) and Iladevi Cataract and IOL Research Centre (ICIRC) in Ahmedabad, India. In 2011, the American Society of Cataract and Refractive Surgeons (ASCRS) gave him the Binkhorst Medal Lecture, making him the first Indian and just the second Asian to get the honour. He has almost 140 publications to his credit.
Kaid Johar SR is an Associate Professor in Department of Zoology and Biomedical TechnologyGujarat University, who specialized in cell and molecular biology, ophthalmology, cancer, and toxicology. He has almost 50 publications in prestigious journals.
press releasesRead more...
Shantha Biologics Partners with Denmark's Novo Nordisk for Cartridge Fill-Finish in Diabetes and Obesity Care
Pharma major Shantha Biologics has announced that it has signed an agreement with Novo Nordisk the Danish pharmaceutical company to manufacture cartridges for injectable medicines at its Hyderabad
Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company
Lonza the worlds leading contract development and manufacturing organization CDMO today announced an expanded strategic collaboration with a leading USbased biopharmaceutical company
Cartherics recognised as Asia Pacific Emerging Leader in Allogeneic Cell Therapy
Cartherics Pty Ltd Cartherics or Company a biotechnology company developing offtheshelf immune cell therapies focusing on highimpact womens diseases with lead programs in ovarian cancer and endometriosis
Icosagen completes €45 million expansion, bringing therapeutic protein discovery, development and GMP manufacturing together under one roof
Estoniabased biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and manufacturing capabilities at a single site creating a seamless pathway
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
Drug developers have a new optimized option for USbased manufacturing as AGC Biologics enters a strategic partnership with Pyramid Pharma Services The collaboration combines AGC Biologics expertise
Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases
VectHorus a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of therapeutic molecules and imaging agents announces a research evaluation and exclusive
EventsRead more...
07 - 09
Jul 2026The Pharma India Expo 2026
Bombay Exhibition Centre, Mumb...
07 - 09
Jul 2026Nanosciences and Nanotechnologies 2026
Thessaloniki, Greece
08 - 10
Jul 2026CPHI SEA 2026
QSNCC, Bangkok, Thailand
09 - 11
Jul 2026Pharma Pro&Pack Expo 2026
HITEX Exhibition Centre, Hyder...
16 - 19
Jul 2026Bio Asia Taiwan 2026
Taipei Nangang Exhibition Cent...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
LATEST NEWSRead more...
Viva Biotech and Adjutor Group Partner to Expand Global Drug Development Services
Viva Biotech and Adjutor Group have announced a collaboration aimed at expanding their international business networks and strengthening engagement with global life sciences partners
Excalipoint Therapeutics partners with Roche to evaluate EXP011 in DLL3-expressing solid tumours
Excalipoint Therapeutics has entered into a clinical trial collaboration with Roche to evaluate its lead product candidate EXP CTM in combination with atezolizumab for the treatment of DLLexpressing solid tumours
Innovent Biologics and Lilly sign commercialisation agreement for Verzenios in mainland China
Innovent Biologics and Eli Lilly and Company have signed a distribution and promotion agreement for Verzenios abemaciclib in mainland China
Roche launches AXELIOS 1 next-generation sequencing platform
Roche has launched AXELIOS its nextgeneration sequencing platform powered by proprietary Sequencing by Expansion SBX technology The new system combines high accuracy rapid sequencing flexibility
Ipsen to acquire Kartos Therapeutics, expanding late-stage haemato-oncology pipeline
Ipsen has entered into a definitive merger agreement to acquire Kartos Therapeutics strengthening its latestage haematooncology pipeline The acquisition adds navtemadlin an investigational MDM inhibitor
Ionis Licenses Zilganersen Rights Outside US to Recordati
Ionis Pharmaceuticals has signed a licensing agreement with Recordati granting the company exclusive rights to develop and commercialise the investigational medicine zilganersen for Alexander disease AxD